Historique
The 2017 National Drug Threat Assessment (NDTA) outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs.
Over the past 10 years, the drug landscape in the United States has s[...]
Auteur US Department of Justice
7 Documents disponibles écrits par cet auteur
The National Drug Threat Assessment outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. Among the key 2018 NDTA findings: Controlled prescription drugs remain respo[...]
The 2019 National Drug Threat Assessment (NDTA) is a comprehensive strategic assessment of the threat posed to the United States by domestic and international drug trafficking and the abuse of both licit and illicit drugs. Illicit drugs, and [...]
The 2020 National Drug Threat Assessment (NDTA) is a comprehensive assessment of the threat posed to the United States by the trafficking and abuse of illicit drugs, the diversion and abuse of licit drugs, and the laundering of proceeds generate[...]
ENGLISH : Heroin signature analysis is conducted at DEA's Special Testing and Research Laboratory (STRL). Initiated in 1977, heroin signature analysis is based on an exhaustive chemical profile of authentic samples acquired from each of the fo[...]
The 2024 National Drug Threat Assessment (NDTA) is a comprehensive strategic assessment of illicit drug threats endangering the United States. DEA's goal in publishing the NDTA is to save American lives by raising awareness and understanding of [...]
The Drug Enforcement Administration (DEA) presents the 2025 National Drug Threat Assessment (NDTA), a comprehensive report that provides a national-level perspective on the threats posed by deadly illicit drugs and the violent transnational crim[...]
